Editorial
Published on 04 Jun 2025
Editorial: Enhancing drug discovery through structure-based design and computational techniques
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1632015
- 321 views
139 Publications
Volume 5 - 2025
Editorial
Accepted on 02 Jun 2025
Editorial: Pharmacokinetics Modeling in the Artificial Intelligence Era
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1636070
- 293 views
Mini Review
Accepted on 02 Jun 2025
AI-Driven Innovation in Antibody-Drug Conjugate Design
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1628789
- 310 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 448 views
Original Research
Accepted on 16 May 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 205 views
Original Research
Published on 15 Apr 2025
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1525533
- 823 views
- 1 citation
Original Research
Published on 21 Feb 2025
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1545391
- 811 views
Editorial
Published on 20 Feb 2025
Editorial: Exploring drug development with single cell omics analytics and stem cell-based disease models
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1561985
- 537 views
Perspective
Published on 19 Feb 2025
Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1536756
- 2,764 views
Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 2,052 views
Volume 4 - 2024
Original Research
Published on 03 Jan 2025
Validation of an MPS-based intestinal cell culture model for the evaluation of drug-induced toxicity
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1459424
- 1,921 views
- 2 citations
Review
Published on 19 Dec 2024
Targeting steroid receptor coactivators in cancer via small molecule agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1514412
- 783 views
Editorial
Published on 29 Nov 2024
Editorial: Drug discovery and development explained: introductory notes for the general public
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1528467
- 1,466 views
Review
Published on 19 Nov 2024
Decoding lung complexity: single-cell sequencing in lung diseases, regeneration, and drug discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1495208
- 1,203 views
Original Research
Published on 29 Oct 2024
Drug–drug interaction extraction based on multimodal feature fusion by Transformer and BiGRU
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1460672
- 813 views
Review
Published on 22 Oct 2024
Single-cell multiomics: a new frontier in drug research and development
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1474331
- 2,243 views